Research

Mixed

Licensed weight-lowering pharmacotherapies (GLP-1RAs, naltrexone/bupropion, phentermine/topiramate) improve self-reported physical function, but do not significantly improve objectively measured physical function, cardiorespiratory fitness, or physical activity levels.

If you are using FDA/EMA-approved weight loss medications, expect improvements in how you feel you function in daily life (self-reported physical function). However, do not expect these medications alone to significantly boost your actual exercise capacity, VO2 max, or daily activity levels without dedicated exercise training. The benefits are modest and primarily subjective.

GoodQualifiesMEDIUM confidence
Improvements in self-reported physical function were observed with weight loss therapy, but the effect on physical activity or objectively measured physical function and fitness could not be determined.
Rishi Jobanputra et al. · Obesity Reviews · 2023

Why this rating

Based on 14 RCTs, but limited by lack of objective fitness/activity data in most studies.

Source

The effects of weight‐lowering pharmacotherapies on physical activity, function and fitness: A systematic review and meta‐analysis of randomized controlled trials

Rishi Jobanputra et al. · Obesity Reviews · 2023

DOI 10.1111/obr.13553

Meta-analysis · 14 studiesCited 22×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →